The Role of Microbial Metabolites in Cancer Prevention and Etiology (U01)

The summary for the The Role of Microbial Metabolites in Cancer Prevention and Etiology (U01) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
The Role of Microbial Metabolites in Cancer Prevention and Etiology (U01): This Funding Opportunity Announcement (FOA) issued by the National Cancer Institute (NCI), and the National Center for Complementary and Alternative Medicine, (NCCAM), at the National Institutes of Health, encourages the submission of grant applications that characterize the effects of microbially generated metabolites of dietary components on host cell biology. Specifically, this FOA seeks to characterize microbially generated metabolites and better understand their molecular mechanisms of action that affect host cell proliferative/apoptotic responses, cytokine production, inflammatory and immunomodulatory effects. This FOA will also encourage the conduct of human intervention studies that identify inter-individual variability among various racial and ethnic groups in the production of bacterial metabolites and determine their efficacy in cancer prevention. This research is necessary to better understand the role of dietary components in cancer etiology, prevention, and cancer health disparities to identify who might benefit from specific dietary recommendations and who might be placed at risk. One of the goals of this program will be to facilitate interdisciplinary collaborations among scientists engaged in nutrition, cancer prevention, cancer cell biology research, and cancer disparities research with those conducting studies with gut microorganisms. All applications must include multiple principle investigators with different areas of expertise such as microbiology, nutrition, cancer biology, analytical chemistry, or genetics. In addition, all investigators will be required to attend annual meetings with NIH personnel. Investigators may use either clinical or preclinical approaches.
Federal Grant Title: The Role of Microbial Metabolites in Cancer Prevention and Etiology (U01)
Federal Agency Name: National Institutes of Health
Grant Categories: Education Health
Type of Opportunity: Discretionary
Funding Opportunity Number: PAR-11-152
Type of Funding: Cooperative Agreement
CFDA Numbers: 93.213
CFDA Descriptions: Research and Training in Complementary and Alternative Medicine
Current Application Deadline: Nov 15, 2012
Original Application Deadline: Nov 15, 2012
Posted Date: Mar 15, 2011
Creation Date: Mar 15, 2011
Archive Date: Dec 16, 2012
Total Program Funding:
Maximum Federal Grant Award:
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching: No
Applicants Eligible for this Grant
State governments - Public and State controlled institutions of higher education - Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education - Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education - Private institutions of higher education - For profit organizations other than small businesses - Small businesses - Others (see text field entitled "Additional Information on Eligibility" for clarification)
Additional Information on Eligibility
Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Eligible Agencies of the Federal Government; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Foreign (non-U.S.) components on applications submitted by U.S. Organizations are allowed.
Link to Full Grant Announcement
http://grants.nih.gov/grants/guide/pa-files/par-11-152.html
Grant Announcement Contact
NIH OER WebmasterFBOWebmaster@OD.NIH.GOV
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [FBOWebmaster@OD.NIH.GOV]
Similar Government Grants
Developing Interventions for Health-Enhancing Physical Activity (R21/R33)
Arts-Based Approaches in Palliative Care for Symptom Management (R01)
Center of Excellence for Natural Product Drug Interaction Research (U54)
Methods Development in Natural Products Chemistry (STTR) (R41)
Methods Development in Natural Products Chemistry (R43/R44)
Probiotics for Pediatric Illnesses
Cam Practitioner Research Education Project Grant Partnership
Complementary and Alternative Medicine Career Transition Award (K22)
More Grants from the National Institutes of Health
Consortium for the Study of Chronic Pancreatitis, Diabetes and Pancreatic Cancer Coordinat...
Consortium for the Study of Chronic Pancreatitis, Diabetes and Pancreatic Cancer Clinical ...
Systems Developmental Biology for Understanding Embryonic Development and the Ontogeny of ...
Limited Competition for the Continuation of Rare Diseases Clinical Research Consortia in t...
Innovative Technologies for Differential Diagnosis of Acute Febrile Illnesses (R21/R33)

FederalGrants.com is not endorsed by, or affiliated with, any government agency. Copyright ©2014 FederalGrants.com